MHS
WST icon

M Holdings Securities’s West Pharmaceutical WST Stock Holding History

M Holdings Securities’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,000
Closed -$45K – 446
2014
Q3 		$45K Buy
+1,000
New +$42.5K 0.03% 397

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

M Holdings Securities's WST Position: Q4 2014 in Review

M Holdings Securities sold out of West Pharmaceutical (WST) in Q4 2014, closing a stake of 1,000 shares — an estimated $45K sold.

M Holdings Securities first reported a position in WST in Q3 2014 and held it in 1 quarter. The position peaked at $45K in Q3 2014. 225 funds tracked by Wall St. Rank hold WST as of Q4 2014.

  • M Holdings Securities reported no remaining West Pharmaceutical position as of Q4 2014 after selling out during the quarter.
  • M Holdings Securities sold 1,000 West Pharmaceutical shares in Q4 2014, an estimated $45K.
  • M Holdings Securities first reported a position in West Pharmaceutical in Q3 2014 and held it in 1 quarter.
  • M Holdings Securities's West Pharmaceutical position peaked at $45K in Q3 2014.
  • 225 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2014.

Based on M Holdings Securities's 13F filing for Q4 2014, filed 13 Feb 2015.